J 58 (Lamivudine and Zidovudine 150 mg / 300 mg)
Pill with imprint J 58 is White, Capsule-shape and has been identified as Lamivudine and zidovudine 150 mg / 300 mg. It is supplied by Aurobindo Pharma Limited.
Lamivudine/zidovudine is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 58
- J 58
- 150 mg / 300 mg
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma Limited
- Inactive Ingredients:
- silicon dioxide
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|68084-0416||Amerisource Health Services|
More about lamivudine/zidovudine
- Lamivudine/zidovudine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Other brands: Combivir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.